NEW YORK (TheStreet) -- CHANGE IN RATINGS
Avago Technologies (AVGO) - Get Report initiated at Barclays with an Overweight rating. Analysts mentioned above average sales growth, improving margins, and strengthening balance sheet. 2009 and 2010 EPS estimates set at $0.63 and $0.99, respectively. $21 price target.
upgraded at Goldman from Neutral to Buy. $31 price target. Stock has lagged its peers and expectations are now low following the CFN spin-off.
rated new Sell at Jesup & Lamont. $16 price target. Earnings growth expectations appear too optimistic for the next couple of years, given poor sales visibility.
upgraded at Wells to Outperform. New analyst also raised estimates, as the company has less late-cycle exposure than previously thought.
upgraded at Argus from Hold to Buy. $38 price target. Management is seeing firmer pricing.
upgraded at Argus from Hold to Buy. $12 price target. Company is trying to lower debt and operating results are stabilizing.
upgraded at UBS from Neutral to Buy. $28 price target. Recent checks suggest that same-store sales are improving.
upgraded at Needham from Buy to Strong Buy. $115 price target. Business fundamentals should get stronger into 2010, led by demand from peering wireless customers.
downgraded at JP Morgan. Rating lowered to Neutral from Overweight. Maintains 2009 EPS estimates of $1.41 and $27.50 price target.
rated new Neutral at Goldman. $17 price target. LCD glass business is approaching a cyclical peak, but the current valuation is reasonable.
downgraded at Merrill/BofA to Neutral from Buy on limited upside potential. However, Merrill raised the price target to $60 from $53. 2009 and 2010 EPS estimates set at $4.80 and $4.25.
downgraded at UBS from Buy to Neutral. Estimates also lowered, as the company has high exposure to rising medical loss trends.
initiated at JP Morgan. Initiated with an Overweight rating and $53 price target. Introduces 2009 EPS estimates of $1.79.
upgraded at Goldman from Sell to Neutral. Stock is already pricing in risks to Tarceva. $34 price target.
upgraded at Credit Suisse to Outperform from Neutral. Price target inflated to $16 from $13. 2009 and 2010 EPS estimates set at $0.96 and $1.31 respectively.
initiated at Thomas Weisel with an Overweight rating and $10 price target. Completed third shale well and drilling fourth well that could be worth $22 per share, said Credit Suisse.
rated new Buy at UBS. $18 price target. Industry dynamics are positive and the company may be able to grow margins by more than expected.
rated new Buy at UBS. $42 price target. Company is a market leader in quickly-growing areas like notebooks and external drives.
upgraded at Barclays to Overweight from Equal Weight on attractive free cash flow yield. Price target boosted to $12 from $8. 2009 and 2010 EPS estimates set at $0.54 and $0.76.
upgraded at Bernstein to Outperform. $21 price target. Stock looks inexpensive on a sum-of-the-parts valuation.
STOCK COMMENTS / EPS CHANGES
target boosted at Goldman to $23. See more stable business fundamentals over the next several quarters. Neutral rating.
price target raised at Credit Suisse to $35 from $27 on attractive valuation. Maintain Neutral rating. 2009 and 2010 EPS estimates set at $1.48 and $1.69, respectively.
target raised at FBR to $21. Company seeing higher trading activity. Market Perform rating.
number lowered at Morgan Stanley. GNW 2009 and 2010 EPS estimates to $0.24 from $0.43 and to $1.20 from $1.35, respectively. Genworth announced $500M+ equity raise. Maintain Equal Weight rating.
estimates cut at Morgan Stanley. LBTYA 2009 and 2010 EPS estimates to $0.67 and $2.60, respectively. Maintain Equal-Weight rating.
estimates, target raised at Goldman. Shares of LLY now seen reaching $34. Estimates were also boosted, to reflect the new restructuring plan. Even so, long-term earnings visibility remains poor. Sell rating.
price target up at Weisel to $55 from $44 based on higher than expected top line growth. 2010 and 2011 EPS estimates set at $4.15 and $4.57, respectively.
target increased at Goldman to $58. Industry fundamentals should improve as the macro environment recovers. Neutral rating.
price target inflated at Merrill/BofA to $10.60 from $9 to reflect forthcoming smartphone launches. Maintain Buy rating. 2009 and 2010 EPS estimates raised to -$0.05 from -$0.13 and to $0.27 from $0.19.
estimates lowered at Citi. NKE 2010 and 2011 EPS estimates to $3.60 from $3.70 and to $4.20 from $4.35, respectively. Valuation very attractive. Reiterate Buy rating and $65 price target.
target lowered at FBR to $15. Company facing a delay in the sale of $20 billion of loans to the government and could see worse near-term performance in the private loan portfolio. Outperform rating.
This article was written by a staff member of TheStreet.com.